/News

At the Adie General meeting which took place on April 11th, Astrid Cloarec, Donatien Noyelle et Yannick Ballandras awarded 3 nominees :

- Prix « Rebond » : Saïda HESSABI, Afghan and french food restaurant/catering services (Auvergne Rhône-Alpes)

- Prix « Vitalité des territoires » : Ivan PURRI, italian restaurant (Auvergne Rhône-Alpes)

- Le Grand Prix CréAdie - Elan d’Idées : Zaven TARZYAN, carpenter/cabinet maker in Thionville (Grand Est)

For further information, please click on Responsible investor/sponsorship.

MMF V has closed its eight investment with the takeover of HELIOS via an LMBO involving Jean-Christophe Blot, chairman, and Christophe Chariot, the managing director of Sallandre.

The Hélios group is a specialist in the secondary construction industry (or ‘second fix’), namely in waterproofing, roofing and plumbing, in the Paris region.
Its origin dates back to 1992 with the creation of GEC Ile-de-France (Générale d’Etanchéité et de Couverture), a specialist in waterproofing roof-terraces and the thermal insulation of buildings. The company was taken over in 2013 by its current manager, Jean-Christophe Blot, via an LBO transaction. Helios further structured itself and diversified around plumbing and thermal installations through the acquisition of Sallandre in 2016.

With its headquarters at Gennevilliers in Paris, the group employs a staff of close to 90 and posted sales of €22 million in FY 2018. Helios has the benefit of solid fundamentals. It is exclusively positioned inside the resilient renovation and maintenance segment and enjoys recurrent activity, with most of its interventions being carried out within the framework of tendered contracts with official purchase orders.

With the support of Azulis Capital, the group aims to strengthen its territorial network via external growth, diversify its customer base, and acquire complementary skills.

Azulis Capital publishes its 2018 ESG report.

Download the PDF report in the section Responsible investor.

The MMV IV Fund has just sold its stake in the Bioclinic Group, a major player in the medical biology sector of the Paris Region.

Founded in 1995 by Philippe Dabi, still managing the Group as of today, the group then developed through external growth via the acquisition of 34 sites over 6 years, thanks to the support of MMF IV. The group’s management has demonstrated its expertise through both external and organic growth in a rapidly consolidating market.

Its founder, supported by a consortium of new financial partners, has strengthened his control on the group so that he is now the major shareholder alongside the management team.